Bumper Offer - Urjas oil Just @ Rs. 1
Vomipen is a prescription medicine that is available as a Injection, Syrup. Primarily, it is used for the treatment of Nausea and Vomiting.
The optimal dosage of Vomipen is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Vomipen can also lead to other problems, which have been listed below. Normally, these side effects of Vomipen are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Vomipen has a Safe effect for pregnant women and Mild effect on lactating mothers. Warnings related to Vomipen's effects on the liver, heart and kidney, if any, have been listed below.
Vomipen can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Vomipen in conditions like Heart Disease, Calcium Deficiency, Potassium Deficiency. Other contraindications of Vomipen have been discussed in the sections ahead.
Additionally, Vomipen may also adversely react with other medicines. See below for a complete list.
You should also be aware that Vomipen is not safe while driving, and is not addiction.
Vomipen is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Infant (1 month to 2 years) |
|
| 2 - 12 years (Child) |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Vomipen is used -
Moderate
Mild
Is the use of Vomipen safe for pregnant women?
There are no side effects of Vomipen in pregnant women.
Is the use of Vomipen safe during breastfeeding?
Breastfeeding women can take Vomipen as it bears very minor side effects for them.
What is the effect of Vomipen on the Kidneys?
Vomipen does not damage the kidneys.
What is the effect of Vomipen on the Liver?
You may experience side effects on your liver after taking Vomipen. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Vomipen on the Heart?
The heart can be affected by Vomipen. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Vomipen should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Vomipen unless your doctor advises you to do so -
Is this Vomipen habit forming or addictive?
No, there is no any evidence that Vomipen is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Vomipen, you should not drive or work on any heavy machine, as Vomipen can make you drowsy.
Is it safe?
Yes, but take Vomipen only as per medical advice.
Is it able to treat mental disorders?
No, the use of Vomipen in mental disorders is not effective.
Interaction between Food and Vomipen
It is safe to take Vomipen with food.
Interaction between Alcohol and Vomipen
Consuming Vomipen with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
